Skip to main content
Professional Technical IVT

R-CHOP

Pronunciation: are-chop

Also written as: R-CHOP — Rituximab-Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone

Standard chemotherapy regimen combining rituximab with CHOP for treating B-cell lymphomas. Cornerstone treatment protocol.

Full Definition

R-CHOP is a widely used chemotherapy regimen that combines rituximab (a monoclonal antibody) with the CHOP chemotherapy backbone consisting of cyclophosphamide, doxorubicin (hydroxydaunorubicin), vincristine (Oncovin), and prednisone. This regimen revolutionized treatment of B-cell non-Hodgkin lymphomas, particularly diffuse large B-cell lymphoma, by adding targeted immunotherapy to conventional cytotoxic chemotherapy. R-CHOP is typically administered in 21-day cycles, and the addition of rituximab significantly improved cure rates compared to CHOP alone.

Usage

Usage note: Always hyphenate R-CHOP. Capitalize all letters in the acronym.

In Context

  • "The patient completed six cycles of R-CHOP with excellent tolerance." — Treatment summary
  • "R-CHOP remains the gold standard for frontline treatment of DLBCL." — Clinical guideline

Also known as

rituximab plus CHOP

Don't confuse with

CHOP R-CVP ABVD

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON